DOR BioPharma, Inc. announced today that the United States Patent and Trademark Office has issued a Notice of Allowance of patent claims based on U.S. Patent Application #09/433,418 entitled "Topical Azathioprine for the Treatment of Oral Autoimmune Diseases." Concurrently, the patent has also been issued by the European Patent Office with the serial number EP 1 212 063 B1. This patent family ...
From: biz.yahoo.com
DOR BioPharma Announces Issuance of Patents for Oral Graft Versus Host Disease
Posted by Ruslan Abuzant at 4:21 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment